Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Holleys 2024 Financial Outlook Growth Strategies and Commitment to Success

Elaine Mendonca by Elaine Mendonca
February 28, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Holley is projecting net sales of $150-160 million for the first quarter of 2024, down from an estimated $178.89 million. For the full year, they anticipate net sales of $640-680 million, slightly below the estimated $681.01 million. Adjusted EBITDA is expected to be $27-33 million for Q1 and $125-145 million for the full year. The company is also forecasting capital expenditures, depreciation and amortization expenses, interest expenses, and a bank-adjusted EBITDA leverage ratio for both periods.

Holley’s 2024 outlook demonstrates their commitment to growth despite potential economic challenges. They plan to simplify operations, drive growth through product strategies, and maintain financial discipline to reach their full potential. Despite a soft Q1 expected due to lower consumer demand, Holley remains confident in their long-term financial goals and debt reduction efforts while improving profitability.

Overall, Holley’s strategic approach for 2024 aims to overcome challenges, streamline operations, and boost growth in the automotive aftermarket industry. S&P Global Ratings has upgraded Holley Inc.’s outlook to positive, reflecting confidence in the company’s future prospects.

HLLY Stock Shows Strong Performance with 6.83% Increase on February 28, 2024

On February 28, 2024, HLLY stock showed strong performance as it closed at $4.85, marking a significant increase of $0.31 since the market last closed. This represents a 6.83% rise in the stock price, indicating positive momentum for the company. According to data from CNN Money, HLLY is currently trading in the middle of its 52-week range and above its 200-day simple moving average. This suggests that the stock is in a stable position and potentially has room for further growth. Despite the strong performance during regular trading hours, the stock remained unchanged in after-hours trading. This could indicate that investors are taking a more cautious approach after the initial surge in price. Overall, HLLY’s stock performance on February 28, 2024, reflects positive momentum and investor confidence in the company. Investors should keep an eye on any future developments or news that may impact HLLY’s stock price.

HLLY Stock Performance on February 28, 2024: Revenue Decline, Net Income Increase, and Fluctuating EPS

On February 28, 2024, HLLY stock experienced mixed performances based on the financial data provided by CNN Money. The total revenue for the company stood at $688.41 million over the past year, with a significant decline to $156.53 million in the most recent quarter. In terms of net income, HLLY reported a net income of $73.77 million over the past year, which saw a substantial increase of 371.84% since the previous year. Earnings per share (EPS) for HLLY stock also saw fluctuations in performance. Overall, the financial data for HLLY stock on February 28, 2024, reflects a mixed performance with fluctuations in revenue, net income, and earnings per share. Investors and analysts may closely monitor the company’s future financial reports to assess its ability to overcome challenges and sustain growth in the market.

Tags: HLLY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Bull Market

Novavax Implements Major Changes to Operations and Finances in Response to Market Conditions

Analyst Increases Price Target for Tarsus Pharmaceuticals

Biotechnology Markets and money

Wedbush Analyst Reiterates Outperform Rating on Denali Therapeutics with 31 Price Target

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com